Upregulation of QKI during PAH results in decreased levels of miR-7, causing de-repression and higher expression of the miR-7 target gene, serine and arginine-rich splicing factor 1 (SRSF1). The gene discussed is SRSF1; the disease is pulmonary arterial hypertension.